[go: up one dir, main page]

NL192604C - Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. - Google Patents

Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. Download PDF

Info

Publication number
NL192604C
NL192604C NL8901840A NL8901840A NL192604C NL 192604 C NL192604 C NL 192604C NL 8901840 A NL8901840 A NL 8901840A NL 8901840 A NL8901840 A NL 8901840A NL 192604 C NL192604 C NL 192604C
Authority
NL
Netherlands
Prior art keywords
ranitidine
bismuth
solution
salt
salts
Prior art date
Application number
NL8901840A
Other languages
English (en)
Dutch (nl)
Other versions
NL192604B (nl
NL8901840A (nl
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8901840A publication Critical patent/NL8901840A/nl
Publication of NL192604B publication Critical patent/NL192604B/xx
Application granted granted Critical
Publication of NL192604C publication Critical patent/NL192604C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL8901840A 1988-07-18 1989-07-17 Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. NL192604C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8817098 1988-07-18
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB8904686 1989-03-01
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (3)

Publication Number Publication Date
NL8901840A NL8901840A (nl) 1990-02-16
NL192604B NL192604B (nl) 1997-07-01
NL192604C true NL192604C (nl) 1997-11-04

Family

ID=26294175

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8901840A NL192604C (nl) 1988-07-18 1989-07-17 Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat.
NL970046C NL970046I2 (nl) 1988-07-18 1997-12-18 Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL970046C NL970046I2 (nl) 1988-07-18 1997-12-18 Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat.

Country Status (35)

Country Link
US (1) US5008256A (fr)
JP (1) JP2523185B2 (fr)
KR (1) KR0122598B1 (fr)
CN (1) CN1022626C (fr)
AT (1) AT398200B (fr)
AU (1) AU632052B2 (fr)
BE (1) BE1003254A5 (fr)
CA (1) CA1332610C (fr)
CH (1) CH679582A5 (fr)
CY (1) CY1650A (fr)
DE (1) DE3923638C2 (fr)
DK (1) DK168381B1 (fr)
EG (1) EG19368A (fr)
ES (1) ES2014175A6 (fr)
FI (1) FI90538C (fr)
FR (1) FR2634122B1 (fr)
GB (1) GB2220937B (fr)
GR (1) GR1000431B (fr)
HK (1) HK61392A (fr)
HU (2) HU206104B (fr)
IE (1) IE61076B1 (fr)
IL (1) IL91005A (fr)
IT (1) IT1231481B (fr)
LU (2) LU88722I2 (fr)
MX (1) MX174145B (fr)
MY (1) MY104055A (fr)
NL (2) NL192604C (fr)
NO (2) NO176319C (fr)
NZ (1) NZ229958A (fr)
PL (1) PL162391B1 (fr)
PT (1) PT91188B (fr)
SE (1) SE468715B (fr)
SG (1) SG51992G (fr)
YU (1) YU47021B (fr)
ZW (1) ZW8689A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
EP0550083B1 (fr) * 1991-12-06 1999-03-24 Glaxo Group Limited Médicaments pour le traitement de conditions inflammatoires ou pour l'analgésie contenants un NSAID et du citrate de bismuth-ranitidine
WO1996019232A1 (fr) * 1994-12-19 1996-06-27 Lauteral Limited Combinaisons d'hydrochlorure de ranitidine de forme 1 et de composes du bismuth
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As, Oslo Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP1035192A1 (fr) * 1999-01-26 2000-09-13 Stefan Graichen Additif pur un réfrigérant lubrifiant
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
WO2015155297A1 (fr) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Combinaisons pharmaceutiques de dabigatran et d'antagonistes du récepteur h2
WO2015169957A1 (fr) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Combinaisons pharmaceutiques de rivaroxaban et d'antagonistes du récepteur h2
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
KR0122598B1 (ko) 1997-11-13
NL970046I1 (nl) 1998-03-02
FI893448A0 (fi) 1989-07-17
FR2634122B1 (fr) 1993-11-19
JPH02117684A (ja) 1990-05-02
AU632052B2 (en) 1992-12-17
GR890100454A (en) 1990-06-27
EG19368A (en) 1995-02-28
PT91188A (pt) 1990-02-08
AT398200B (de) 1994-10-25
CN1022626C (zh) 1993-11-03
SG51992G (en) 1992-07-24
ZW8689A1 (en) 1990-02-21
CA1332610C (fr) 1994-10-18
MX174145B (es) 1994-04-25
CY1650A (en) 1992-12-11
DE3923638A1 (de) 1990-03-01
IE61076B1 (en) 1994-09-21
YU142789A (en) 1991-04-30
CH679582A5 (fr) 1992-03-13
DK168381B1 (da) 1994-03-21
HUT52082A (en) 1990-06-28
FR2634122A1 (fr) 1990-01-19
HU211173A9 (en) 1995-11-28
YU47021B (sh) 1994-11-15
NL192604B (nl) 1997-07-01
JP2523185B2 (ja) 1996-08-07
GR1000431B (el) 1992-07-30
PL162391B1 (pl) 1993-10-30
NL970046I2 (nl) 1998-04-01
GB8916288D0 (en) 1989-08-31
LU87557A1 (fr) 1990-07-24
NZ229958A (en) 1991-09-25
FI893448A (fi) 1990-01-19
ES2014175A6 (es) 1990-06-16
DK351789D0 (da) 1989-07-17
NO892936D0 (no) 1989-07-17
DE3923638C2 (de) 1995-11-23
FI90538C (fi) 1994-02-25
GB2220937A (en) 1990-01-24
KR910002826A (ko) 1991-02-26
SE468715B (sv) 1993-03-08
LU88722I2 (fr) 1996-08-23
SE8902550D0 (sv) 1989-07-17
CN1039419A (zh) 1990-02-07
IL91005A0 (en) 1990-02-09
FI90538B (fi) 1993-11-15
HK61392A (en) 1992-08-21
PT91188B (pt) 1995-03-01
NO176319B (no) 1994-12-05
MX16829A (es) 1993-10-01
NO1998007I1 (no) 1998-02-05
AU3817889A (en) 1990-01-18
MY104055A (en) 1993-10-30
GB2220937B (en) 1991-11-27
HU206104B (en) 1992-08-28
ATA172889A (de) 1994-02-15
IL91005A (en) 1994-10-07
BE1003254A5 (fr) 1992-02-11
DK351789A (da) 1990-01-19
NL8901840A (nl) 1990-02-16
SE8902550L (sv) 1990-01-19
IT1231481B (it) 1991-12-07
IE892309L (en) 1990-01-18
IT8948196A0 (it) 1989-07-17
US5008256A (en) 1991-04-16
NO176319C (no) 1995-03-15
NO892936L (no) 1990-01-19

Similar Documents

Publication Publication Date Title
NL192604C (nl) Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat.
KR101226669B1 (ko) Ｎ,ｎ－디메틸 이미도디카르본이미딕 디아미드의 디카르복실산염, 그의 제조 방법 및 그의 약제학적 조성물
SA99200064B1 (ar) مشتقات إيميدازو بيريدين imidazo pyridine المثبطة لإفراز الحمض المعدي acid secretion
DE69108913T2 (de) 4-alkylimidazolderivate.
KR0148480B1 (ko) 히스타민 h2-수용체 길항제의 염 및 용매화물
EP0445743A2 (fr) Complexes et chélates de l'azithromycine comme agents anti-ulcère
JPS6126996B2 (fr)
JPH05117259A (ja) カルボン酸誘導体
CN103601673B (zh) 3-羟基吡啶-4-酮的氟化衍生物
RU2114857C1 (ru) Соли, образованные ранитидином и комплексным соединением висмута с карбоновой кислотой, и фармацевтический препарат
CN112839934B (zh) 一种沃诺拉赞盐及其制备方法与用途
SI8911427A (sl) Postopek za pripravo soli ranitidina z bizmutovimi kompleksi karboksilnih kislin
CZ285821B6 (cs) Sůl tvořená ranitidinem a komlexem vizmutu s karboxylovou kyselinou, farmaceutický prostředek s obsahem této soli a způsob přípravy uvedené soli
JPH0688974B2 (ja) ２−ピリジルアセタミド誘導体、その製法および用途
JPH01501387A (ja) ２―メチルメルカプト―３―シアノ―４―（０―ジフルオロメトキシフェニル）―６―フェニル―１，４―ジヒドロピリジン

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
AC1 Application for a supplementary protection certificate

Free format text: 970046, 971218

KC1 Grant of a supplementary protection certificate

Free format text: 970046, 20090717, EXPIRES: 20100713

V1 Lapsed because of non-payment of the annual fee

Effective date: 20070201